Medlab Clinical Ltd. (MDLB)

Medlab Clinical Income Statement

Financials in millions USD. Fiscal year is July - June.

Year Ending	TTM	Jun 30, 2022	Jun 30, 2021
Revenue	1.54	1.54	0.73
Revenue Growth (YoY)	-	109.68%	-
Cost of Revenue	0.34	0.34	0.02
Gross Profit	1.2	1.2	0.72
Selling, General & Admin	3.95	3.95	3.22
Research & Development	1.5	1.5	2.1
Other Operating Expenses	8.73	8.73	8.62
Operating Expenses	14.18	14.18	13.94
Operating Income	-12.98	-12.98	-13.23
Interest Expense / Income	0.06	0.06	0.11
Other Expense / Income	-5.81	-5.81	-0.94
Pretax Income	-7.16	-7.16	-12.32
Net Income	-7.23	-7.23	-12.4
Net Income Common	-7.16	-7.16	-12.32
Free Cash Flow	-9.44	-9.44	-10.43
Gross Margin	78.11%	78.11%	97.76%
Operating Margin	-845.13%	-845.13%	-1804.94%
Profit Margin	-466.19%	-466.19%	-1681.90%
Free Cash Flow Margin	-614.57%	-614.57%	-1423.78%
EBITDA	-6.32	-6.32	-11.42
EBITDA Margin	-411.42%	-411.42%	-1557.94%
Depreciation & Amortization	0.85	0.85	0.87
EBIT	-7.17	-7.17	-12.29
EBIT Margin	-466.79%	-466.79%	-1677.15%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).